SELLAS Life Sciences Group Investor Relations Material
Latest events
Study Update
SELLAS Life Sciences Group
Q1 2025
13 May, 2025
Q4 2024
20 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SELLAS Life Sciences Group Inc
Access all reports
SELLAS Life Sciences Group Inc. is a biopharmaceutical company focused on developing immunotherapies for cancer. The company specializes in targeted peptide-based therapies designed to stimulate the immune system against various tumor types. Its research and development efforts aim to advance novel cancer treatments through clinical trials and regulatory approvals. The company is headquartered in Montvale, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
SLS
Country
🇺🇸 United States